An observational study in Cataract, sponsored by Clínica Rementería. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-29.
Sponsored by Clínica Rementería · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 61 studies in Cataract with a site in Spain — 12 open to participants now, 13 under way, none of them phase 3. Cataract · Spain.
Among the 61 studies in Cataract with a site in Spain, this one is the 8th largest by enrollment of the 27 observational ones that give a count, is one of 4 that started in 2019, is one of 27 observational ones, and was the 13th registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →12 of the 61 studies in Cataract with a site in Spain are open now. Recruiting first, the newest first:
Carl Zeiss Meditec AG · Sites in Spain, Czechia, Germany and 1 more country
Ages 18+
Z Optics, Inc. · Sites in Spain, Portugal, Switzerland
Ages 40–75
AST Products, Inc. · Sites in Spain
Ages 40+
Alcon Research · Sites in Spain, United States, India and 1 more country
Ages 18+
OMIQ Research · Sites in Spain
Ages 50+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
61 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 4 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 100 is above the median of 90 across 477 observational studies indexed under Cataract.
Median enrollment 100 across the 34 interventional studies, 60 across the 27 observational. Of the 46 that completed or were terminated, 4 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
50 of 61 have an industry lead sponsor. The 10 most frequent:
Clínica Rementería is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Clínica Rementería has 1 study filed under Cataract — fewer than ten, so there is no comparison to draw.
3 of the studies in Cataract with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07232615Biotech Healthcare Holding GmbhA Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses Used in Cataract Surgery | 2026-12 |
| NCT06987474Alcon ResearchCapella Scientia Development Study | 2027-05 |
| NCT05955846Z Optics, Inc.Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 61 studies in Cataract with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Multifocal lens allow most patients to be spectacle-free after cataract surgery. Most studies published up-to-date have focused on visual acuity, but not on patient-reported outcomes. Since some patients with very good postoperative visual acuity report being very uncomfortable after surgery, the aim of this study is to evaluate if patient satisfaction is correlated with other outcomes, such as low-contrast visual acuity, contrast sensitivity, photic phenomena and ability to tolerate defocus. Patients who have undergone surgery with bilateral multifocal intraocular lens implantation will be carefully evaluated 3 months after surgery to try to determine the factors that correlate with patient reported outcomes as evaluated with the Catquest SF-9 questionnaire.
Patients who have undergone bilateral cataract surgery with bilateral implantation of a multifocal intraocular lens and who are willing to participate in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Evaluation of patient satisfaction after bilateral cataract surgery with multifocal intraocular lens implantation
Patient satisfaction
Patient satisfaction with visual outcome three months after surgery as evaluated with the Catquest-9 questionnaire
Time frame: Three months after surgery
Plan to share: Undecided
Ran from Feb 2019 to primary completion in Dec 2020, 22 months.
Of 169 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's 22 months is above that.
Counting every sponsor, half of 236 studies reached it within 16 months; a quarter within 9 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clínica Rementería